Skip to content
  • Share
  • Listen


Start of Coverage: 14-09-2010

Resume of the last report made by this analyst

In the relative valuation, we have increased the premium on average peer multiples. Jeronimo Martins is healthier (in terms of lfl prospects, profitability and ROE) and is better placed to blunt the ongoing COVID-19 issue.

Analyst: Nishant Choudhary


The information presented refers to recommendations issued by analysts that follow the Jerónimo Martins’ share. For more information, please read the Analysts Coverage section in this website’s Terms and Conditions.